Number | Title | Threat Areas | Action | Announced | Close |
BARDA-CBRN-10-100-SOL-00012
|
ARA290 Hematopoietic
|
Radiological Even/Exposure
|
Contract Awarded to Araim
|
Sep 2011
|
|
BARDA-CBRN-10-100-SOL-00012
|
Noval antimicrobials
|
Broad Spectrum Antibiotics
|
Contract Awarded to GSK
|
Sep 2011
|
|
BARDA-CBRN-10-100-SOL-00012
|
Monoclonal IM Formulation
|
Anthrax Antitoxins
|
Contract Awarded to Elusys
|
Sep 2011
|
|
BARDA-CBRN-10-100-SOL-00012
|
Somatostatin-like
|
Radiological Even/Exposure
|
Contract Awarded to Univ. of Arkansas
|
Sep 2011
|
|
BARDA-CBRN-10-100-SOL-00012
|
nano-DTPA oral forumulation
|
Radiological Even/Exposure
|
Contract Awarded to Nanotherapeutics
|
Sep 2011
|
|
BARDA-CBRN-10-100-SOL-00012
|
Adeno based rPA
|
Anthrax Vaccines
|
Contract Awarded to Vaxin
|
Sep 2011
|
|
BARDA-CBRN-10-100-SOL-00012
|
GI ARS LPA therapeutic
|
Radiological Even/Exposure
|
Contract Awarded to RXBIO
|
Sep 2011
|
|
BARDA-CBRN-10-100-SOL-00012
|
HemaMax (rhuIL-12)
|
Radiological Even/Exposure
|
Contract Awarded to Neumedicines
|
Aug 2011
|
|
BARDA-BAA-09-100-SOL-00010
|
Multiplexed Flu Immunity Assay
|
Innovation
|
Contract Awarded to MesoScale
|
Aug 2011
|
|
BARDA-CBRN-10-100-SOL-00012
|
Intranasal Amyl Nitrate (for cyanide)
|
Chemical Threats
|
Contract Awarded to Southwest Research Inst.
|
Aug 2011
|
|
BARDA-CBRN-10-100-SOL-00012
|
In vivo electron paramagnetic resonance system
|
Biodosimetry
|
Contract Awarded to Dartmouth
|
Aug 2011
|
|
BARDA-CBRN-10-100-SOL-00012
|
Galantamine (for volatile nerve agents)
|
Chemical Threats
|
Contract Awarded to Countervail Corp
|
Aug 2011
|
|
BARDA-CBRN-BAA-09-34
|
ABC294640 for GI ARS
|
Acute Radiation Syndrome
|
Contract Awarded to Apogee
|
Jul 2011
|
|
BARDA-CBRN-10-100-SOL-00012
|
AVX-470 for GI ARS
|
Acute Radiation Syndrome
|
Contract Awarded to Avaxia
|
Jul 2011
|
|
BARDA-CBRN-10-100-SOL-00012
|
Label Comprehension Study
|
Broad Spectrum Antibiotics
|
Contract Awarded to SNBL
|
Jul 2011
|
|
BARDA-CBRN-10-100-SOL-00012
|
BIO-300
|
Acute Radiation Syndrome
|
Contract Awarded to Humanetics Corporation
|
Jun 2011
|
|
RFP-BARDA-10-100-SOL-00025
|
Animal Model Development IDIQ
|
Biological, Chemical, RAD/NUC Threats
|
Contract Awarded to IDIQ: Base Contracts Awarded to 12 Vendors
|
May 2011
|
|
BARDA-CBRN-BAA-11-100-SOL-00009
|
BARDA-CBRN-BAA-11-100-SOL-00009
|
Biodefense
|
|
Feb 2011
|
Mar 2012
|
BARDA-CBRN-10-100-SOL-00012
|
Lung MCM Angiotensis II
|
Radiological Even/Exposure
|
Contract Awarded to US Biotest
|
Feb 2011
|
|
RFP-11-100-SOL-00007
|
ST-246 Development and delivery of 1.7M treatment courses to the SNS
|
Smallpox
|
Contract Awarded to SIGA for $433,000,000.00
|
Feb 2011
|
|
RFP-BARDA-10-101
|
Pediatric Formulation for Prussian Blue
|
Radiological Even/Exposure
|
Contract Awarded to Heyltex
|
Feb 2011
|
|
BARDA-CBRN-10-100-SOL-00012
|
Smallpox Antiviral
|
Smallpox
|
Contract Awarded to Chimerix
|
Feb 2011
|
|
BARDA-CBRN-10-100-SOL-00012
|
Skin MCM Antioxidant
|
Chemical Pulmonary Agents
|
Contract Awarded to Aeolus
|
Feb 2011
|
|